Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

V Anagnostou, N Niknafs, K Marrone, DC Bruhm…�- Nature cancer, 2020 - nature.com
Despite progress in immunotherapy, identifying patients that respond has remained a
challenge. Through analysis of whole-exome and targeted sequence data from 5,449�…
Save Cite Cited by 170 Related articles

Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

V Anagnostou, N Niknafs, K Marrone…�- Nature�…, 2020 - pubmed.ncbi.nlm.nih.gov
Despite progress in immunotherapy, identifying patients that respond has remained a
challenge. Through analysis of whole-exome and targeted sequence data from 5,449�…
Cite
[HTML] nih.gov

[HTML][HTML] Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

V Anagnostou, N Niknafs, K Marrone, DC Bruhm…�- Nature�…, 2020 - ncbi.nlm.nih.gov
Despite progress in immunotherapy, identifying patients that respond has remained a
challenge. Through analysis of whole-exome and targeted sequence data from 5,449�…
Cite

Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.

V Anagnostou, N Niknafs, K Marrone, DC Bruhm…�- Nature Cancer, 2020 - europepmc.org
Despite progress in immunotherapy, identifying patients that respond has remained a
challenge. Through analysis of whole-exome and targeted sequence data from 5,449�…
Cite

Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

V Anagnostou, N Niknafs, K Marrone…�- Nature�…, 2020 - pure.johnshopkins.edu
Despite progress in immunotherapy, identifying patients that respond has remained a
challenge. Through analysis of whole-exome and targeted sequence data from 5,449�…
Cite

[CITATION][C] Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

V Anagnostou, N Niknafs, K Marrone, DC Bruhm…�- Nature Cancer, 2020 - cir.nii.ac.jp
Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell
lung cancer | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ[サイニィ] 詳細へ�…
Cite

Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer.

V Anagnostou, N Niknafs, K Marrone, DC Bruhm…�- Nature Cancer, 2020 - europepmc.org
Despite progress in immunotherapy, identifying patients that respond has remained a
challenge. Through analysis of whole-exome and targeted sequence data from 5,449�…
Cite